Country-to-country transfer of patients and the risk of multi-resistant bacterial infection

Clinical Infectious Diseases

Volumn 53, Issue 1, 2011, Pages 49-56

  Rogers, Benjamin A ^a   Aminzadeh, Zohreh ^a,b   Hayashi, Yoshiro ^a,c   Paterson, David L ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ENZYME; CARBAPENEM; CARBAPENEMASE; EXTENDED SPECTRUM BETA LACTAMASE; METALLO BETA LACTAMASE;

ACINETOBACTER; ACINETOBACTER INFECTION; AEROSPACE MEDICINE; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BELGIUM; CITROBACTER FREUNDII; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE TRANSMISSION; EMPIRICISM; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FRANCE; GRAM NEGATIVE BACTERIUM; HEALTH CARE ORGANIZATION; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; IRELAND; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MEDICAL TOURISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PATIENT TRANSPORT; POPULATION DISTRIBUTION; POPULATION RISK; PRIORITY JOURNAL; REVIEW; SOLDIER; TRAUMATIC BRAIN INJURY; VANCOMYCIN RESISTANT ENTEROCOCCUS;

BACTERIAL INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MEDICAL TOURISM; PATIENT TRANSFER; RISK FACTORS;

EID: 79958815193     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir273     Document Type: Review

References (73)

1. International Air Transport Association. Passenger numbers to reach 2.75 billion by 2011. Available at: http://www.iata.org/pressroom/pr/Pages/2007-24- 10-01.aspx. Accessed 30 August 2010.
2. Ayliffe GA. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1997; 24(Suppl 1):S74-9.
3. Livermore DM, Pearson A. Antibiotic resistance: location, location, location. Clin Microbiol Infect 2007; 13(Suppl 2):7-16. (Pubitemid 46711384)
4. Uckay I, Sax H,Harbarth S, Bernard L, Pittet D.Multi-resistant infections in repatriated patients after natural disasters: lessons learned from the 2004 tsunami for hospital infection control. J Hosp Infect 2008; 68:1-8.
5. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother 2009; 64(Suppl 1):i3-10.
6. Commercially motivated renal transplantation: results in 540 patients transplanted in India. The Living Non-Related Renal Transplant Study Group. Clin Transplant 1997; 11:536-44.
7. Zinn CS, Westh H, Rosdahl VT. An international multicenter study of antimicrobial resistance and typing of hospital Staphylococcus aureus isolates from 21 laboratories in 19 countries or states. Microb Drug Resist 2004; 10:160-8. (Pubitemid 38879017)
8. Paterson DL, Ko WC, Von Gottberg A, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extendedspectrum beta-lactamase production in nosocomial Infections. Ann Intern Med 2004; 140:26-32. (Pubitemid 38055918)
9. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-96. (Pubitemid 43810035)
10. Teichman PG, Donchin Y, Kot RJ. International aeromedical evacuation. N Engl J Med 2007; 356:262-70. (Pubitemid 46143229)
11. Wilde H, Roselieb M, Hanvesakul R, Phaosavasdi S, Pruksapong C. Expatriate clinics and medical evacuation companies are a growth industry worldwide. J Travel Med 2003; 10:315-7. (Pubitemid 38094912)
12. Duchateau FX, Verner L, Cha O, Corder B. Decision criteria of immediate aeromedical evacuation. J Travel Med 2009; 16:391-4.
13. Maegele M, Gregor S, Steinhausen E, et al. The long-distance tertiary air transfer and care of tsunami victims: injury pattern and microbiological and psychological aspects. Crit Care Med 2005; 33:1136-40. (Pubitemid 40638192)
14. Tran MD, Garner AA, Morrison I, Sharley PH, Griggs WM, Xavier C. The Bali bombing: civilian aeromedical evacuation. Med J Aust 2003; 179:353-6. (Pubitemid 37265128)
15. Heath CH, Orrell TC, Lee RC, Pearman JW, McCullough C, Christiansen KJ. A review of the Royal Perth Hospital Bali experience: an infection control perspective. Healthcare Infection 2003; 8:43-54.
16. Kaspar RL, Griffith ME, Mann PB, et al. Association of bacterial colonization at the time of presentation to a combat support hospital in a combat zone with subsequent 30-day colonization or infection. Mil Med 2009; 174:899-903.
17. Petersen K, Riddle MS, Danko JR, et al. Trauma-related infections in battlefield casualties from Iraq. Ann Surg 2007; 245:803-11. (Pubitemid 46684112)
18. Fischer D, Veldman A, Schafer V, Diefenbach M. Bacterial colonization of patients undergoing international air transport: a prospective epidemiologic study. J Travel Med 2004; 11:44-8. (Pubitemid 38198775)
19. Kaiser AM, Schultsz C, Kruithof GJ, Debets-Ossenkopp Y, Vandenbroucke-Grauls C. Carriage of resistant microorganisms in repatriates from foreign hospitals to the Netherlands. Clin Microbiol Infect 2004; 10:972-9. (Pubitemid 39562464)
20. Rice DH, Kotti G, Beninati W. Clinical review: critical care transport and austere critical care. Crit Care 2008; 12:207.
21. Zapor MJ, Erwin D, Erowele G, Wortmann G. Emergence of multidrug resistance in bacteria and impact on antibiotic expenditure at a major army medical center caring for soldiers wounded in Iraq and Afghanistan. Infect Control Hosp Epidemiol 2008; 29:661-3. (Pubitemid 352009393)
22. Jones A, Morgan D, Walsh A, et al. Importation of multidrug-resistant Acinetobacter spp infections with casualties from Iraq. Lancet Infect Dis 2006; 6:317-8. (Pubitemid 43737279)
23. Yun HC, Branstetter JG, Murray CK. Osteomyelitis in military personnel wounded in Iraq and Afghanistan. J Trauma 2008; 64(Suppl 2):S163-8; discussion S168.
24. Scott P, Deye G, Srinivasan A, et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis 2007; 44:1577-84. (Pubitemid 46871504)
25. Carrera PM, Bridges JF. Globalization and healthcare: understanding health and medical tourism. Expert Rev Pharmacoecon Outcomes Res 2006; 6:447-54. (Pubitemid 44304753)
26. Keckley PH, Underwood HR. Medical tourism: update and implications. Washington, DC: Deloitte Center for Health Solutions, 2009.
27. Reed CM. Medical tourism. Med Clin North Am 2008; 92:1433-46,xi.
28. Lunt N, Carrera P. Medical tourism: assessing the evidence on treatment abroad. Maturitas 2010; 66:27-32.
29. Statement on medical and surgical tourism. Bull Am Coll Surg 2009; 94:26-7.
30. American Medical Association. Medical care outside the United States. Vol H-450.937. Chicago: American Medical Association, 2008.
31. Youngman I. Truth behind the statistics. Available at: http://www.imtj.com/articles/2008/truth-behind-the-statistics/. Accessed 30 August 2010.
32. Birch J, Caulfield R, Ramakrishnan V. The complications of 'cosmetic tourism'-an avoidable burden on the NHS. J Plast Reconstr Aesthet Surg 2007; 60:1075-7. (Pubitemid 47087221)
33. Gill J, Madhira BR, Gjertson D, et al. Transplant tourism in the United States: a single-center experience. Clin J AmSoc Nephrol 2008; 3:1820-8.
34. Yakupoglu YK, Ozden E, Dilek M, et al. Transplantation tourism: high risk for the recipients. Clin Transplant 2010; 24:835-8.
35. Canales MT, Kasiske BL, Rosenberg ME. Transplant tourism: outcomes of United States residents who undergo kidney transplantation overseas. Transplantation 2006; 82:1658-61. (Pubitemid 46035647)
36. Prasad GV, Shukla A, Huang M, Rj Dah, Zaltzman JS. Outcomes of commercial renal transplantation: a Canadian experience. Transplantation 2006; 82:1130-5. (Pubitemid 44748012)
37. Overseas Pakistanis Foundation. Available at: http://www.opf.org.pk. Accessed 6 December 2010.
38. The Indian Diaspora. Available at: http://indiandiaspora.nic.in/. Accessed 6 December 2010.
39. Sidjabat H, Nimmo GR, Walsh TR, et al. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo-beta-lactamase. Clin Infect Dis 2011; 52:481-4.
40. Muir A, Weinbren MJ. New Delhi metallo-beta-lactamase: a cautionary tale. J Hosp Infect 2010; 75:239-40.
41. Poirel L, Revathi G, Bernabeu S, Nordmann P. Detection of NDM-1- producing Klebsiella pneumoniae in Kenya. Antimicrob Agents Chemother 2010; 55:934-6.
42. Bogaerts P, Naas T, Wybo I, et al. Outbreak of infection by carbapenem- resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium. J Clin Microbiol 2006; 44:4189-92. (Pubitemid 44737268)
43. Moro M, Nizzero P, Biancardi A, et al. An outbreak caused by multidrugresistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy. J Hosp Infect 2008; 68:97-9.
44. Scott PT, Peterson K, Fishbain J, et al. Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb Mortal Wkly Rep 2004; 53:1063-6.
45. Navon-Venezia S, Leavitt A, Schwaber MJ, et al. First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob Agents Chemother 2009; 53:818-20.
46. Giakoupi P, Maltezou H, Polemis M, Pappa O, Saroglou G, Vatopoulos A. KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill 2009; 14:69-73.
47. Wendt C, Schutt S, Dalpke AH, et al. First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis 2010; 29:563-70.
48. Naas T, Nordmann P, Vedel G, Poyart C. Plasmid-mediated carbapenemhydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother 2005; 49:4423-4. (Pubitemid 41401006)
49. Woodford N, Zhang J, Warner M, et al. Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother 2008; 62:1261-4.
50. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10:597-602.
51. Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009; 53:5046-54.
52. Health Protection Agency. Multi-resistant bacteria linked to India and Pakistan. Health Protection Report 2009; 3:1-4.
53. Detection of Enterobacteriaceae isolates carrying metallo-betalactamase- United States, 2010. MMWR Morb Mortal Wkly Rep 2010; 59:750.
54. Struelens MJ, Monnet DL, Magiorakos AP, Santos O'Connor F, Giesecke J. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill 2010; 15:11-16.
55. Bogaerts P, Verroken A, Jans B, Denis O, Glupczynski Y. Global spread of New Delhi metallo-beta-lactamase 1. Lancet Infect Dis 2010; 10: 831-2.
56. Kuster SP, Hasse B, Huebner V, et al. Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland. Infection 2010; 38:33-40.
57. Shannon KP, King A, Phillips I, Nicolas MH, Philippon A. Importance of organisms producing broad-spectrum SHV-group betalactamases into the United Kingdom. J Antimicrob Chemother 1990; 25:343-51. (Pubitemid 20126999)
58. Pitout JD, Campbell L, Church DL, Gregson DB, Laupland KB. Molecular characteristics of travel-related extended-spectrum-betalactamase- producing Escherichia coli isolates from the Calgary Health Region. Antimicrob Agents Chemother 2009; 53:2539-43.
59. Freeman JT, McBride SJ, Heffernan H, Bathgate T, Pope C, Ellis-Pegler RB. Community-onset genitourinary tract infection due to CTX-M- 15-producing Escherichia coli among travelers to the Indian subcontinent in New Zealand. Clin Infect Dis 2008; 47:689-92.
60. Deplano A, Witte W, van Leeuwen WJ, Brun Y, Struelens MJ. Clonal dissemination of epidemic methicillin-resistant Staphylococcus aureus in Belgium and neighboring countries. Clin Microbiol Infect 2000; 6:239-45. (Pubitemid 36267427)
61. Stenhem M, Ortqvist A, Ringberg H, et al. Imported methicillinresistant Staphylococcus aureus, Sweden. Emerg Infect Dis 2010; 16:189-96.
62. Tietz A, Frei R, Widmer AF. Transatlantic spread of the USA300 clone of MRSA. N Engl J Med 2005; 353:532-3. (Pubitemid 41127306)
63. Willems RJ, Top J, van Santen M, et al. Global spread of vancomycinresistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 2005; 11:821-8. (Pubitemid 40720841)
64. Klare I, Konstabel C, Mueller-Bertling S, et al. Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. Eur J Clin Microbiol Infect Dis 2005; 24:815-25. (Pubitemid 43042788)
65. Ergani-Ozcan A, Naas T, Baysan BO, et al. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital. J Antimicrob Chemother 2008; 61:1033-9. (Pubitemid 351524445)
66. Werner G, Coque TM, Hammerum AM, et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 2008; 13:8-18.
67. Simonsen GS, Myhre MR, Dahl KH, Olsvik O, Sundsfjord A. Typeability of Tn1546-like elements in vancomycin-resistant enterococci using long-range PCRs and specific analysis of polymorphic regions. Microb Drug Resist 2000; 6:49-57. (Pubitemid 30367850)
68. Long S, Fenelon L, Fitzgerald S, et al. First isolation and report of clusters of Clostridium difficile PCR 027 cases in Ireland. Euro Surveill 2007; 12:E070426 3.
69. Riley TV, Thean S, Hool G, Golledge CL. First Australian isolation of epidemic Clostridium difficile PCR ribotype 027. Med J Aust 2009; 190:706-8.
70. Tachon M, Cattoen C, Blanckaert K, et al. First cluster of C. difficile toxinotype III, PCR-ribotype 027 associated disease in France: preliminary report. Euro Surveill 2006; 11:E060504 1.
71. Fidler DP, Gostin LO. The new International Health Regulations: an historic development for international law and public health. J Law Med Ethics 2006; 34:85-94, 4. (Pubitemid 43448622)
72. Tangden T, Cars O, Melhus A, Lowdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTXM- type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010; 54: 3564-8.
73. Kennedy K, Collignon P. Colonisation with Escherichia coli resistant to "critically important" antibiotics: a high risk for international travellers. Eur J Clin Microbiol Infect Dis 2010; 29:1501-6.